Frontonasal dysplasia
|
0.760 |
GeneticVariation
|
disease |
BEFREE |
Genome scan using 250k Nsp1 array followed by exome and Sanger sequence analysis revealed a novel homozygous nonsense variant (c.604C>T, p.Gln202*) in the ALX3 gene resulting in frontorhiny in the family.
|
29215096 |
2018 |
Frontonasal dysplasia
|
0.760 |
Biomarker
|
disease |
BEFREE |
Frontonasal dysplasia (FND) is a heterogeneous group of disorders characterized by hypertelorism, telecanthus, broad nasal root, wide prominent nasal bridge, short and wide nasal ridge, broad columella and smooth philtrum.
|
27324866 |
2017 |
Frontonasal dysplasia
|
0.760 |
GeneticVariation
|
disease |
BEFREE |
Only a small number of genes have been associated with FND phenotypes until now, the first gene being EFNB1, related to craniofrontonasal syndrome (CFNS) with craniosynostosis in addition, and more recently the aristaless-like homeobox genes ALX3, ALX4, and ALX1, which have been related with distinct phenotypes named FND1, FND2, and FND3 respectively.
|
24376213 |
2014 |
Frontonasal dysplasia
|
0.760 |
Biomarker
|
disease |
BEFREE |
Frontonasal Dysplasia (FND) and Oculo-auriculo-vertebral spectrum (OAVS) are two well-recognized clinical entities.
|
23637006 |
2013 |
Frontonasal dysplasia
|
0.760 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetic determinants of facial clefting: analysis of 357 candidate genes using two national cleft studies from Scandinavia.
|
19401770 |
2009 |
Frontonasal dysplasia
|
0.760 |
Biomarker
|
disease |
BEFREE |
We conclude that ALX3 is essential for normal facial development in humans and that deficiency causes a clinically recognizable phenotype, which we term frontorhiny.
|
19409524 |
2009 |
Frontonasal dysplasia
|
0.760 |
GeneticVariation
|
disease |
UNIPROT |
We conclude that ALX3 is essential for normal facial development in humans and that deficiency causes a clinically recognizable phenotype, which we term frontorhiny.
|
19409524 |
2009 |
Frontonasal dysplasia
|
0.760 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We conclude that ALX3 is essential for normal facial development in humans and that deficiency causes a clinically recognizable phenotype, which we term frontorhiny.
|
19409524 |
2009 |
Frontonasal dysplasia
|
0.760 |
GermlineCausalMutation
|
disease |
ORPHANET |
We conclude that ALX3 is essential for normal facial development in humans and that deficiency causes a clinically recognizable phenotype, which we term frontorhiny.
|
19409524 |
2009 |
Frontonasal dysplasia
|
0.760 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
We conclude that ALX3 is essential for normal facial development in humans and that deficiency causes a clinically recognizable phenotype, which we term frontorhiny.
|
19409524 |
2009 |
Frontonasal dysplasia
|
0.760 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Frontonasal dysplasia, neuronal migration error and lymphoedema of limbs.
|
15127764 |
2004 |
Frontonasal dysplasia
|
0.760 |
Biomarker
|
disease |
BEFREE |
An inbred pedigree is described in which three members were affected with FND (Frontonasal Dysplasia).
|
7363499 |
1980 |
Frontonasal dysplasia
|
0.760 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Frontonasal dysplasia
|
0.760 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Frontonasal dysplasia
|
0.760 |
Biomarker
|
disease |
CTD_human |
|
|
|